- The Covid-19 epidemic has severely affected cancer screening and treatment in 17 European countries.
- A million cancer patients may not have been diagnosed.
- In France, a delay of 200 days has been accumulated for chemotherapy.
“The Covid-19 pandemic has had major consequences on care and cancer patients in Europe”. This is the observation that the European Cancer Organization made from data collected by its new tool called “Data Navigator”. This device, which has just been launched, brings together the information available in order to provide the data necessary to quantify the impact of Covid-19 on cancer treatment and screening in Europe.
One million cancer victims of the health crisis
According to the European Cancer Organization, the health crisis, which has delayed diagnoses or postponed treatment of cancer patients, has seriously affected cancer screening and treatment in 17 European countries. Among them, we find Italy, Denmark, Ireland and France.
Data collected by the “Data Navigator” revealed that around 100 million drug tests were not carried out due to the pandemic in 2020 in Europe. According to this tool, one million cancer patients may have gone undiagnosed due to the backlog of screening tests, delays in referral and limited health resources due to the pandemic. .
A delay of 200 days for chemotherapy
In France, the number of cancers detected in April 2020 fell by 42% compared to April 2019. As for treatment, a delay of 200 days has been accumulated for chemotherapy. “38% of patients said they were anxious about going to a medical facility because of Covid-19”, indicates the tool created by the European Cancer Organization.
“The Data Navigator provides further demonstration of the extent of the consequences of Covid-19 on the fight against cancer and on cancer care across Europe, highlighting the need for urgent action to catch up with the delays in care and rebuilding more resilient health systems “, said Matti Aapro, president of the organization.